Cataplexy
Information
- Disease name
- Cataplexy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00174174 | Completed | N/A | Provigil (Modafinil) Study by Taiwan Biotech Co. | September 2003 | |
| NCT01067222 | Completed | Phase 3 | Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy | May 2009 | December 2010 |
| NCT01067235 | Completed | Phase 3 | Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy | October 2009 | July 2010 |
| NCT01399606 | Completed | Phase 3 | Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) | May 2011 | September 2016 |
| NCT02720744 | Completed | Phase 3 | Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy | November 17, 2016 | March 25, 2020 |
| NCT02913651 | Completed | Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia | January 2016 | December 2016 | |
| NCT04451668 | Completed | Phase 3 | An Open Label Study of FT218 in Subjects With Narcolepsy | June 12, 2020 | December 22, 2023 |
| NCT05059223 | Completed | Phase 3 | A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy | September 15, 2021 | March 15, 2024 |
| NCT05113745 | Enrolling by invitation | Phase 3 | A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy | October 20, 2021 | December 2024 |
| NCT05615584 | Recruiting | N/A | Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence | February 15, 2023 | October 30, 2025 |
| NCT03425214 | Unknown status | N/A | Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder | January 19, 2018 | June 30, 2019 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0002428
- HPO alt_id (Human Phenotype Ontology)
- HP:0002525
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002524
- MedGen concept unique identifier (MedGen Concept name)
- C0007384
- MedGen unique identifier (MedGen Concept name)
- 2862
- MeSH unique ID (MeSH (Medical Subject Headings))
- D002385